Lupin’s partner ForDoz receives USFDA approval for doxorubicin hydrochloride liposome injection
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
The company shall be engaged in the business of manufacturing of pharmaceutical, bio-pharmaceutical and biological products of any kind
A special purpose vehicle (SPV) formed by O2 Energy SG Pte Ltd, for generation and supply of renewable power
Company hires life science veteran Jessica Cao to join management team
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
John served as General Manager for Catalent Pharma Solutions in St. Petersburg, Florida
 
        Subscribe To Our Newsletter & Stay Updated